Zytiga Cures Early Stage Prostate Cancer

Zytiga was designed for clinical use as an effective agent against very advanced stage prostate cancer so treatment of early stage disease should be easy for Zytiga. This has been borne out in results of a clinical trial announced in abstracts of the 2012 ASCO conference show that 6 month neoadjuvant treatment with Zytiga results in complete dissapearance of prostate cancer in patients with high risk disease. In one third of patients there was significant tumour regression indicating that Zytiga is an exciting agent for neoadjuvant therapy of prostate cancer which may circumvent the need for surgery in some cases.

Cancers Cured by Salvestrols

Here is a comprehensive list of cancer that have responded to Salvestrol Therapy. In some cases there were partial responses with the disease being contained to a managable level, whilst in other cases complete cures have occured with patients being completely cancer free within 6 months.

Acute Lymphoytic Leukaemia ALL
Chronic Lymphocytic Leukaemia CLL
Acute Myeloid Leukaemia AML
Bladder Cancer
Brain Cancer
Breast Cancer
Bone Cancer
Colon Cancer
Colorectal Cancer
Endometrial Cancer
Head & Neck Cancer
Hogkins Lymphoma
Kidney Cancer RCC
Lung Cancer
Liver Cancer
Lymphoma
Melanoma
Multiple Myeloma MM
Non Hogkins Lymphoma
Oesophagael Cancer
Osteosarcoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Skin Cancer
Stomach Cancer
Soft Tissue Sarcoma
Thyroid Cancer
Testicular Cancer

Other Diseases which have responded to Salvestrols include:

Heart Disease (Lowering of Cholesterol)
Arthritis (Decreased Bone Pain)
Parkinsons Disease (Increased Cognition)
Multiple Sclerosis MS (Myolin Protection)

Cancer Cure Found in Vegetables

The cure for cancer is found in all vegetables containing salvestrols

Forbidden Cancer Cures

A Cuban Pharmacy - Full of forbidden cures for cancer banned in the west by legislation.
Some are banned in the west because they work too well and threaten the pharmaceutical industries billion dollar profits from cancer chemotherapy, such as the simple Hoxsey Remedy and Essiac Formula.
Others are banned because they are downright dangerous such as Escozul the venom from the cuban blue scorpion.

Cancer Cure in Fruits & Vegetables

Cancer fighting fruits and vegetables rich in salvestrol

Breast Cancer Survivor Recommends Salvestrol Platinum

I would like to say that I swear by a supplement called Salvestrol Platinum. I've been taking it since my diagnosis of stage 3 breast cancer 5 years ago in 2007. Like all natural things, there's no double-blind trials offering scientific 'proof' but the theory behind it makes sense to me so I'm going to keep taking it as long as I live, as it is meant to be highly 'anti-cancer' and as a bonus it seems to do wonders for my skin. After diagnosis, I stopped taking lymecyclene and thought I would just have to put up with nasty spots. But as soon as I started taking Salvestrols the improvement in my skin was astonishing and fast. They are not expensive at about £1 per day. I'm lucky that I can afford it - I buy supplements and good food rather than spend my money on meals out, etc. That's my suggestion. Good luck with whatever you decide to try.

It's not my profession or anything to do with making money. This is material I researched myself upon diagnosis, because I wanted to try and help myself rather than rely just on what conventional medicine offers/insists on, and I think this advice will help others who have breast cancer. The main evidence I have is that I have recovered from cancer and feel much better than before I was diagnosed - and I mean both physically and mentally better. When I stray from my routine of diet and supplements, it shows in my skin very quickly - so I have come to believe my skin is a 'barometer' of my internal health.

Salvestrols are based on the idea that the anti-fungal, anti-bacterial and anti-cancer properties of fruits and veg reside in the skin of the fruit and have been largely destroyed by food processing and the last 6 decades of industrial farming. So even if you eat lots of fruit and veg, they may no longer provide you with the healthy nutrients they did when agriculture was more natural, when the plants had to use their own immune systems to fight disease - rather than pesticides and fungicides doing this for them.

So Salvestrols are made from older varieties of fruits and veg, ones that have not been industrially farmed, and therefore retain their own immune defenses which are beneficial when eaten. In terms of cancer, salvestrols are said to be able to break through the protein coating of cancer cells, and trigger an enzyme inside the cancer cell to make it die.

That's the theory. Best wishes, B

Abiraterone Cures Prostate Cancer

New UK research confirms the groundbreaking cancer drug abiraterone provides significant benefit for up to two-thirds of men on long term treatment for over 5 years with advanced and aggressive prostate cancer, according to a study published online in the Journal of Clinical Oncology.

The drug was discovered by Professor Gerry Potter at The Institute of Cancer Research (ICR) in the Cancer Research UK Centre for Cancer Therapeutics, and made headlines in July 2008 when the first UK Phase I clinical trial reported significant shrinkage of patients’ tumours and reduction in pain. Scientists hailed it as one of the most significant developments in prostate cancer in 60 years.

This second publication of a Phase I/II study, reporting on 54 patients, confirms the Phase I results. In addition, ICR scientists have worked out how to delay drug resistance and developed a test to identify the men most likely to benefit from abiraterone.

These Phase I/II studies were undertaken by the ICR and The Royal Marsden NHS Foundation Trust and were funded by Cougar Biotechnology Inc. The lead researchers on the study were funded by Cancer Research UK.

Lead researcher Dr Gert Attard says:

“Phase I/II results showed that up to 70 per cent of men responded to the drug, abiraterone. About two-thirds of men experienced significant benefits for an average of eight months, with scans showing their tumours decreased in size and their PSA levels dropped substantially.

“Our latest study also shows that by combining abiraterone with a steroid treatment when abiraterone stops working, we can reverse resistance and extend the response to this treatment by another 12 months.

 “We have also noticed that the majority of patients who had very significant shrinkage of their tumours had an abnormality of a gene called ERG that was probably driving their cancer. We have developed a test for this ERG gene so we can identify the men most likely to benefit from abiraterone.”

Chief investigator Dr Johann de Bono is extremely optimistic about these results:

“Almost all these men had cancer that had spread to the bones, lymph glands and elsewhere. Many were in pain and not enjoying life. The patients involved in this trial remained pain-free for an average of about eight months, a brilliant result for those with aggressive prostate cancer and their families. For about a third of men – those who carried the ERG gene - the benefit lasted for more than 18 months.

“In addition, this drug has changed the way the science community looks at prostate cancer. It can block the production of male hormones, including hormones produced by the tumour itself. The more we learn about how this drug works the more we will be able to find further ways of counteracting a patient’s potential genetic resistance to it.”

Mike Torr, 70, from Sheffield, was involved in the Phase II abiraterone clinical trial. He says: "Five years ago, I was in severe pain as my prostate cancer had spread to my bones. I was involved in the earlier trials and received the additional steroid treatment to combat resistance. This drug has given me over five years of life, symptom-free. I have been cured of advanced prostate cancer. I have been able to go back to fully enjoying my retirement and travelling with my wife to places such as India."

Abiraterone is currently in Phase III prostate cancer trials at more than 150 hospitals across the world, in one of the largest ever trials for end-stage prostate cancer. More than 1300 men have been treated with the drug and it is hoped that, should the trials continue to show a benefit, abiraterone may be available for general use as a prostate cancer treatment by 2011.

Professor Peter Johnson, chief clinician at Cancer Research UK, which helped fund the lead investigators on the study, said: “These early results hold great promise for treating a problem which affects many men with prostate cancer and give us real hope for the future. We are keen to see the results of the larger trials now underway, to find out whether abiraterone should be made generally available. This drug is an excellent example of how research which leads to better understanding of the biology of a cancer can give us new opportunities for its treatment.”